- Home
- UUU vs QNRX Comparison
UUU vs QNRX Comparison
Compare UUU & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- QNRX
- Stock Information
- Founded
- UUU 1969
- QNRX 2018
- Country
- UUU United States
- QNRX United States
- Employees
- UUU N/A
- QNRX N/A
- Industry
- UUU Electronic Components
- QNRX Medical/Dental Instruments
- Sector
- UUU Technology
- QNRX Health Care
- Exchange
- UUU Nasdaq
- QNRX Nasdaq
- Market Cap
- UUU 5.2M
- QNRX 5.3M
- IPO Year
- UUU N/A
- QNRX N/A
- Fundamental
- Price
- UUU $2.31
- QNRX $0.57
- Analyst Decision
- UUU
- QNRX Strong Buy
- Analyst Count
- UUU 0
- QNRX 1
- Target Price
- UUU N/A
- QNRX $4.00
- AVG Volume (30 Days)
- UUU 34.4K
- QNRX 1.4M
- Earning Date
- UUU 02-18-2025
- QNRX 03-12-2025
- Dividend Yield
- UUU N/A
- QNRX N/A
- EPS Growth
- UUU N/A
- QNRX N/A
- EPS
- UUU N/A
- QNRX N/A
- Revenue
- UUU $21,288,232.00
- QNRX N/A
- Revenue This Year
- UUU N/A
- QNRX N/A
- Revenue Next Year
- UUU N/A
- QNRX N/A
- P/E Ratio
- UUU N/A
- QNRX N/A
- Revenue Growth
- UUU N/A
- QNRX N/A
- 52 Week Low
- UUU $1.11
- QNRX $0.43
- 52 Week High
- UUU $2.47
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- UUU 52.93
- QNRX 43.80
- Support Level
- UUU $2.25
- QNRX $0.56
- Resistance Level
- UUU $2.35
- QNRX $0.63
- Average True Range (ATR)
- UUU 0.06
- QNRX 0.07
- MACD
- UUU -0.01
- QNRX -0.00
- Stochastic Oscillator
- UUU 40.00
- QNRX 11.56
About UUU Universal Security Instruments Inc.
Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.